EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST).
Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better identification of positional OSA. Incorporating positional data provides a more complete diagnostic picture of the patient’s sleep: ABM research found that 21% of sleep apnea patients would have little-to-no breathing problems if back-sleeping were avoided, 1 and that 70% of patients diagnosed with OSA are substantially more severe when back-sleeping. 2 With such an addressable patient population, many physicians are reluctant to switch to new home sleep testing modalities that lack a position sensor.
“The integration is designed to help recognize more patients who may have a positional component contributing to the severity of their sleep-disordered breathing,” stated Daniel J Levendowski, President, Advanced Brain Monitoring, Inc. “This improvement in the HSAT could result in a more personalized approach for first-line OSA therapy recommendations and/or improved selection of alternative therapies for patients who fail to adapt to CPAP.”
The FDA-cleared Night Shift records positional data that will be displayed in EnsoSleep PPG Study Management and can be added to dynamic patient reports.
Incorporating more data through multi-night, multi-sensor testing will provide a more comprehensive understanding of overall sleep issues across the patient population, allowing providers to better diagnose conditions like positional sleep apnea.
“When one in five patients suffering from OSA can be treated with simple body position adjustment therapy, it’s time to address that patient population head on,” stated Brock Hensen, COO, EnsoData. “By adding sleep position data provided by
1 https://pubmed.ncbi.nlm.nih.gov/25126032/
2 https://pubmed.ncbi.nlm.nih.gov/33990168/
Advanced Brain Monitoring’s Night Shift, we can instill physician confidence in new home sleep testing modalities that provide accurate diagnostic data in simple, affordable form factors to replace aging legacy devices.”
Source: Ensodata
